Follicular lymphoma - rituximab

Rituximab for the treatment of follicular lymphoma

Description

Rituximab (given with cyclophosphamide, vincristine and prednisolone) is recommended as a possible treatment for people with symptomatic stage III or IV follicular lymphoma who haven't been treated before.

• Recommendations
• Supporting evidence

Guidance documents

• Guidance Web format  | PDF format
• Quick reference guide PDF format
• NICE guidance written for patients and carers PDF format
• TA110 Follicular lymphoma - rituximab: guidance (MS Word format)
• TA110 Follicular lymphoma - rituximab: understanding NICE guidance (MS Word format)
• TA110 Rituximab ar gyfer trin lymffoma ffoliglaidd: deall canllawiau NICE (fformat MS Word)

Implementing this guidance

• Audit support
• Costing report

Other information

• Background information

We will consult on our review plans for this guidance in June 2009